[ad_1] Gilead Sciences (GILD) followed up a strong quarterly report with a third Food and Drug Administration approval for cancer…
Read More »Gileads
[ad_1] Gilead Sciences (GILD) and Arcus Biosciences (RCUS) notched another win for their cancer program on Monday, briefly pushing GILD…
Read More »